CD274 and ovarian carcinoma: Although mutating or deleting the PD-L1 gene can provide important information on the role of intracellular PD-L1 in ovarian cancer progression [15,16], it is necessary to employ approaches to inhibit intracellular PD-L1 in a manner that is both physiologically and clinically relevant.